FRANCE – ANSES: Prohibited co-formulants, implementation of Regulation (EU) 2026/1120

On 26 June 2026, Anses published a note regarding the implementation of the regulatory provisions concerning prohibited co-formulants as set out in Regulation (EU) 2026/1120 of 20 May 2026, which entered into force on 16 June 2026. This regulation added 12 new co-formulants to Annex III of Regulation (EC) No 1107/2009 and set provisions for Member states as regards the review of the composition of the plant protection products and adjuvants currently authorised in their territory.

Existing marketing authorisations

Authorisation holders of products containing one or more newly listed co-formulants must inform Anses as soon as possible and no later than 31 July 2026. This declaration must be made by completing a specific form and sending it by email to a dedicated address (coformulants2026@anses.fr).

In this form, holders must indicate whether they plan to submit an application for a change in composition or whether such an application has already been submitted. Any proposed minor change to the composition must be submitted as quickly as possible and no later than 16 June 2027.

The marketing authorisations of the concerned products will be withdrawn in the following cases:

• Failure to submit an application for a change in composition by 16 June 2027,
• Application declared administratively inadmissible,
• Negative assessment conclusions.

Prior to any authorisation withdrawal, a procedure initiated by Anses will allow the parties to present their views, in accordance with Article L.122-1 of the French Code of Relations between the Public and the Administration. Authorisation holders will have 10 working days to submit their comments to Anses regarding the letter of intention to withdraw the authorisation.

The withdrawal of the authorisations will take effect no later than 16 June 2028; the maximum grace periods granted will be 3 months for the sale and distribution of the products and 12 months for their use and storage, starting from the date of withdrawal.

Applications for new authorisations currently under assessment

For products containing a co-formulant newly listed in Annex III following the entry into force of Regulation (EU) 2026/1120, where an application for authorisation was submitted before 16 June 2026, and is currently under assessment, an application for a non-significant change in composition may be submitted as soon as possible, and no later than 16 December 2026. The procedure to be followed is the one applicable to modifications of information declared in a pending application.

If no such application is submitted, a decision to refuse the authorisation will be issued.

To download (in French) : 

Implementation of Regulation (EU) 2026/1120 on prohibited co-formulants

See also our previous articles: 

EUROPE – COM: New regulation for the addition of unacceptable co-formulants 

Lynxee consulting’s team is at your disposal to answer your questions.

Contact us! https://lynxee.consulting/en/contact/

Photo credit: Paulo_Corceiro/pixabay